Belinostat resolves skin barrier defects in atopic dermatitis by targeting the dysregulated miR-335:SOX6 axis.

Liew WC, Sundaram GM, Quah S, Lum GG, Tan JSL, Ramalingam R, Common JEA, Tang MBY, Lane EB, Thng STG, Sampath P
J Allergy Clin Immunol. 2020 Feb 21. pii: S0091-6749(20)30259-1. doi: 10.1016/j.jaci.2020.02.007. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.